These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30016794)

  • 1. Intravenous Sotalol: An Under Used Treatment Strategy.
    Kerin NZ
    Cardiology; 2018; 140(3):143-145. PubMed ID: 30016794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Intravenous Sotalol in Cardiac Arrhythmias.
    Samanta R; Thiagalingam A; Turner C; Lakkireddy DJ; Kovoor P
    Heart Lung Circ; 2018 Nov; 27(11):1318-1326. PubMed ID: 29853342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation.
    Jacobson JL; Somberg JC; Nguyen HH
    Pediatr Cardiol; 2020 Feb; 41(2):418-422. PubMed ID: 31664485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic actions of DL-sotalol in ventricular and supraventricular arrhythmias.
    Singh BN
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S75-90. PubMed ID: 1279313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration/response relations for the multiple antiarrhythmic actions of sotalol.
    Woosley RL; Barbey JT; Wang T; Funck-Brentano C
    Am J Cardiol; 1990 Jan; 65(2):22A-27A; discussion 35A-36A. PubMed ID: 2294688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.
    Chow MS
    Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Milan DJ; Saul JP; Somberg JC; Molnar J
    Cardiology; 2017; 136(1):52-60. PubMed ID: 27554842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Amiodarone and Sotalol Impair Contractility and Cardiac Output, but Procainamide Does Not: A Langendorff Study.
    Mackin C; DeWitt ES; Black KJ; Tang X; Polizzotti BD; van den Bosch SJ; Alexander ME; Kheir JN
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):288-297. PubMed ID: 30497293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drugs: present and future.
    Sharma S
    J Assoc Physicians India; 2007 Apr; 55 Suppl():43-6. PubMed ID: 18368867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
    Kirschenbaum HL; Rosenberg JM
    Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intravenous amiodarone in the management of cardiac arrhythmias.
    Desai AD; Chun S; Sung RJ
    Ann Intern Med; 1997 Aug; 127(4):294-303. PubMed ID: 9265430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early experience with intravenous sotalol in children with and without congenital heart disease.
    Valdés SO; Miyake CY; Niu MC; de la Uz CM; Asaki SY; Landstrom AP; Schneider AE; Rusin CG; Patel R; Lam WW; Kim JJ
    Heart Rhythm; 2018 Dec; 15(12):1862-1869. PubMed ID: 30003959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.